Table 2

Baseline clinical parameters in non-motor, motor and levodopa response strata

Non-Motor Symptom Scale
‘Mild to moderate’‘Severe’‘Very severe’
(≤40)(41–70)(≥71)
nMeanSDnMeanSDnMeanSDP value
PDQ-8 Summary Index5626.212.35033.713.36041.415.5 <0.001***
Hoehn and Yahr Scale
‘Minimal to mild’‘Moderate’‘Severe’
(≤ 2.5)(3)(≥ 4)
nMeanSDnMeanSDnMeanSDP value
PDQ-8 Summary Index9631.314.54837.214.71937.316.70.105
Levodopa challenge test response
‘Low’‘Partial’‘Full’
(<33%)(33%–50%)(>50%)
nMeanSDnMeanSDnMeanSDP value
PDQ-8 Summary Index4334.214.15534.115.56633.715.80.947
  • Kruskal-Wallis tests were performed for independent samples for between-strata analyses of baseline parameters. Multiple comparisons (three strata) were corrected with the Bonferroni method.

  • Bold font highlights significant results.

  • ***p<0.001.

  • PDQ-8, 8-item Parkinson’s Disease Questionnaire.